Lauren Santye, Assistant Editor

Study provides visualization of different conformations of transporter in motion that may lead to more effective anticancer and antiviral drugs.

Sheila Arquette, RPh, director of pharmacy services at Independent Health, discusses the lessons of high cost drugs such as PCSK9 inhibitors on specialty pharmacy.

Opioid epidemic fuels hepatitis C transmission.

Findings may lead to the development of a noninvasive clinical diagnostic test.

Eric Peacock, CEO of MyHealthTeams, discusses effective treatment of patients with chronic conditions.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses how the needs of specialty pharmacy, payers, and manufacturers can be aligned.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses high drug costs and the specialty pharmacy patient.

Cutting supply of essential nutrients restrains tumors.

Estimates of patients with HCV dropped from 130 million to 71 million.

Blood test quickly and accurately identifies genetic mutations linked to non-small cell lung cancer.

Key factor helps drive metastases in aggressive cancers.

Rinku A. Patel, PharmD, RPh, discusses how to improve communication among patients, physicians, pharmacists, and payers.

Study provides first direct evidence of HIV persistence in tissue macrophages in vivo, which could lead to a cure for HIV.

Statins also found to lower rates of decompensation in patients with liver cirrhosis related to nonalcoholic steatohepatitis.

Major life events regarding close personal relationships may play a role in mortality.

Statins could be used as adjuvant therapy to prevent decompensation, study suggests.

Midostaurin demonstrated a statistically significant improvement in overall survival among AML patients.

Top news of the day from across the health care landscape.

Stivarga expanded to include the treatment of hepatocellular carcinoma in patients previously treated with sorafenib.

Stivarga is the first FDA-approved treatment for hepatocellular carcinoma in almost a decade.

Positivity interventions may influence health outcomes in people living with HIV.

High levels of the Cd14 gene increases gut barrier integrity.

Top news of the day from across the health care landscape.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses how specialty pharmacies will be impacted by the growth of accountable care organizations.

Unexpected survival gains observed in glioblastoma patients administered an investigational dendritic cell vaccine and temozolomide.

The substantial adverse impact of second cancers may explain the lack of improvement in young adult survival compared with older adults.

Efforts to reduce injection frequency can have positive health benefits with or without HIV infection, study suggests.

Increased development of biosimilars will drive the need for analytical instrument analyzers, report finds.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses how specialty pharmacies can help patients gain access to costly specialty drug regimens.

Increased expression of EGFR-positive myeloid cells associated with tumor progression and reduced survival in bowel cancer.